ADPT

Adaptive Biotechnologies Stock Price

45.83
-0.57 (-1.23%)
Upgrade to Real-Time
Afterhours (Closed)
45.83
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Adaptive Biotechnologies Corporation ADPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.57 -1.23% 45.83 17:15:00
Open Price Low Price High Price Close Price Previous Close
46.72 44.69 47.04 45.83 46.40
Bid Price Ask Price Spread News
43.50 47.56 4.06 - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,158 552,084 $ 45.68 $ 25,218,297 740,654 15.26 - 54.20
Last Trade Time Type Quantity Stock Price Currency
19:53:49 1 $ 45.84 USD

Adaptive Biotechnologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.27B 136.77M 80.93M $ 85.07M $ - -1.53 -56.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adaptive Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADPT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week48.7149.483244.3046.70922,193-2.88-5.91%
1 Month48.6453.831544.3048.63760,328-2.81-5.78%
3 Months40.9954.2034.7546.85904,7734.8411.81%
6 Months42.0054.2034.7543.83978,8673.839.12%
1 Year28.7054.2015.2636.181,035,44917.1359.69%
3 Years39.0155.120315.2636.16902,7226.8217.48%
5 Years39.0155.120315.2636.16902,7226.8217.48%

Adaptive Biotechnologies Description

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.


Your Recent History
NASDAQ
ADPT
Adaptive B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.